Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title [RadioTransNet, the French network for preclinical research in oncological radiotherapy]
Creator Bayart et al.
Author E. Bayart
Author D. Azria
Author J. Balosso
Author M. Benderitter
Author E. Cohen-Jonathan Moyal
Author G. Delpon
Author E. Deutsch
Author M. Dutreix
Author T. Lacornerie
Author P. H. Romeo
Author V. Marchesi
Author P. Maingon
Abstract The ambition of the RADIOTRANSNET network, launched by the INCa at the end of 2018, is to create a French research consortium dedicated to preclinical radiotherapy to foster scientific and clinical interactions at the interface of radiotherapy and radiobiology, and to identify research priorities dedicated to innovation in radiotherapy. The activities of the network are organized around four major axes that are target definition, normal tissue, combined treatments and dose modelling. Under the supervision of the Scientific Council, headed by a coordinator designated by the SFRO and a co-coordinator designated by the SFPM, three leaders coordinate each axis: a radiation-oncologist, a medical physicist and a biologist, who are responsible for organizing a scientific meeting based on the consensus conference methodology to identify priority issues. The selected themes will be the basis for the establishment of a strategic research agenda and a roadmap to help coordinate national basic and translational research efforts in oncological radiotherapy. This work will be published and will be transmitted to the funding institutions and bodies with the aim of opening dedicated calls to finance the necessary human and technical resources. Structuration of a preclinical research network will allow coordinating the efforts of all the actors in the field and thus promoting innovation in radiotherapy.
Publication Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique
Volume 23
Issue 6-7
Pages 609-616
Date 2019-10
Journal Abbr Cancer Radiother
Language fre
DOI 10.1016/j.canrad.2019.07.155
ISSN 1769-6658
Library Catalog PubMed
Extra Number: 6-7 PMID: 31455590
Tags Biomedical Research, Calculs de dose, Combined Modality Therapy, Combined treatments, Dose modelling, France, Health Physics, Humans, Medical physics, Neoplasms, Network, Organs at Risk, Physique médicale, Preclinical research, Radiation Oncology, Radiobiologie, Radiobiology, Radiothérapie oncologique, Radiotherapy, Radiotherapy Dosage, Recherche préclinique, Réseau, review, Traitements combinés
Date Added 2023/11/23 - 12:48:22
Date Modified 2023/11/23 - 12:48:22
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés